Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized transglutaminase site-specific antibody conjugation

Optimized transglutaminase site-specific antibody conjugation

US Patent 11786603 · Granted Oct 17, 2023

Estimated economic value: $132,448,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Method for preparing surface-modified lithium/sodium multicomponent cathode mate2025
Anti-TMPRSS6 antibodies and uses thereof2025
Steroids and protein-conjugates thereof2025
Steroids and protein-conjugates thereof2025
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof2025
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof2025
Therapeutic uses of anti-GITR antibodies2025
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof2025
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof2025
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof2025